35% SALE ON NEW YEAR 35% SALE ON NEW YEAR 35% SALE ON NEW YEAR 35% SALE ON NEW YEAR 35% SALE ON NEW YEAR 35% SALE ON NEW YEAR

25%

off sitewide

happy New site

PROYUPEP5

Ends in

d
h
m
s

RESEARCH PRODUCT

THE RESEARCH EVENT      50% OFF · 10 SELECTED COMPOUNDS

Resets in

CJC1295 (no Dac)

CJC-1295 (no DAC) is a growth hormone–releasing hormone (GHRH) analogue provided for research applications investigating pulsatile growth hormone secretion and endocrine signalling pathways.

Price range: £31.99 through £40.00

Product Specifications:Contents: CJC-1295 without DAC
Size: 5mg, 10mg
Form: Lyophilized powder
Purity: >99%

 

Product Overview
CJC-1295 (no DAC), also known as Modified

GRF (1-29), is a 29-amino-acid synthetic peptide analogue of growth hormone-releasing hormone (GHRH). It is utilized in scientific literature to investigate short-acting, pulsatile growth hormone (GH) secretion and pituitary axis feedback mechanisms.

Active Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
Quantity: 5 mg
Physical Form: Lyophilized powder
Purity Standard: Greater than 99% (HPLC / Mass Spectrometry verified)
Research Domain: Endocrine signaling, anterior pituitary secretion, and metabolic regulation

Mechanistic Profile in Research

Pulsatile GH Release: Modified GRF (1-29) binds

to the GHRH receptor on pituitary somatotropes, triggering a natural, transient spike in growth hormone secretion that mimics endogenous physiological release.
Absence of Drug Affinity Complex (DAC): Without the affinity-complex linker that binds serum albumin, CJC-1295 (no DAC) has a short half-life (approximately 30 minutes in research models), preventing continuous, non-physiological elevation of GH levels.
Synergy with GHRPs: In research models, co-administration with growth hormone secretagogues (like Ipamorelin or GHRP-2) produces a synergistic effect on GH release by acting through distinct but complementary receptor pathways.
IGF-1 Downstream Signaling: Studies measure downstream hepatic expression of Insulin-like Growth Factor 1 (IGF-1) following pulsatile GHRH stimulation to evaluate systemic anabolic

signaling.

Handling and Storage Protocol

Reconstitution: Dilute using sterile Bacteriostatic Water (0.9% Benzyl Alcohol). Direct the diluent slowly down the inside glass wall of the vial and gently swirl until fully dissolved. Do not shake vigorously.
Lyophilized Form: Store at -20 degrees C for long-term preservation; protect from ambient light.
Reconstituted State: Keep refrigerated at 2 degrees C to 8 degrees C and use within 28 days to preserve molecular stability. Avoid repeated freeze-thaw cycles.

This product is provided strictly for laboratory research and analytical testing by qualified scientific professionals. It is not approved for human or veterinary administration, diagnostic

protocols, or therapeutic applications.

Recommended Products

JOIN THE PROYU PEPTIDES COMMUNITY

Receive occasional updates about research materials, product availability, and news from our team.

Frequently Asked Questions

Are Certificates of Analysis available?

Where documentation is available, the COA section lets you review reported analytical results for the batch identified in the report.

Browse the product catalogue, choose the listed research materials you need, and complete the checkout steps.

Visit the Bulk Orders page to learn about available pricing options and submit an enquiry for your requested quantities.

Timing depends on the destination and shipping service selected. Refer to the Shipping & Delivery page for current estimates and tracking details.